NEW DELHI, February 12, 2018 /PRNewswire/ --
The Indian subsidiary of Igenomix has shifted to its all-new biglab this new year. The lab has also been updated with the most advanced equipment for targeted sequencing of the genes, Ion S5 Next-Generation Sequencing (NGS) Systems by Thermofisher. The simple cartridge-loaded reagents and a straightforward
(Logo: http://mma.prnewswire.com/media/449323/PRNE_Igenomix_Logo.jpg )
(Photo: https://mma.prnewswire.com/media/640832/Igenomix_India_Lab.jpg )
The NGS technology is a high-throughput methodology enabling the rapid sequencing of the base pairs in DNA or RNA samples. It supports the broad range of applications, including gene expression profiling, chromosome counting, detection of epigenetic changes, and molecular analysis. With the application of Ion S5 in the NGS systems, targeted sequencing of genes is now simpler than ever.
Why Ion S5 NGS systems are better over any other NGS systems:
With the simplest DNA-to-data workflow for targeted sequencing with industry-leading speed and affordability, Ion S5 in NGS systems allows to spend less time doing repetitive lab work, and more time answering the critical questions in the research. The Ion S5 Systems are the only benchtop NGS platforms with run times as short as 2.5 hours, and rapid DNA-to-data workflows that can be completed in as little as 24 hours.
The new lab which is in the heart of south Delhi, Green Park area is operational from January 2018.
With more than 20 years of industry experience, Igenomix is now present in over 50 countries with more than 12 labs worldwide. Boasting of their efforts in Research and Development, Igenomix is always the first one to adopt the latest technologies worldwide.
Igenomix, an international biotechnology company is offering progressive services in reproductive genetics. Its combined experience and advanced research abilities make it one of the world leaders in this field and guarantee the provision of effective solutions personalized to different infertility problems. It is present in Valencia (Spain), Miami, Los Angeles, New York, Mexico City, UK, Japan, Sao Paulo, Dubai, Delhi, Turkey and Argentina with a workforce of over 180 professionals.
Further information about the company at https://www.igenomix.co.in/
Media Contact: Divya Bhasin firstname.lastname@example.org +91-9958065684 Marketing Manager- India and UAE Igenomix
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All